Inveniam Group

Inveniam is a boutique consulting firm founded in 2013, with headquarters in Barcelona, Spain, and additional operations in Israel. The firm specializes in transaction and strategy advisory services, focusing on technology-based deals in life sciences and resource sustainability. Inveniam assists a diverse range of clients, including start-ups, researchers, corporations, and public institutions, throughout the entire deal life cycle. Their services encompass opportunity scouting, assessment, commercialization, deal structuring, and closing. With a team that brings together various expertise and industry insights, Inveniam aims to bridge the gap between technology originators and the market, providing specialized support that enhances the potential of technology ventures. The firm's global reach is strengthened through strategic alliances and collaborations.

Oliver Yorke

Associate

1 past transactions

AtG Therapeutics

Seed Round in 2022
AtG Therapeutics is a spin-off from the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology in Barcelona, focusing on the discovery and development of innovative therapeutic techniques to combat cancer resistance. The company is dedicated to creating novel classes of drugs and biomarkers aimed at preventing therapeutic resistance in cancer treatment. By advancing new mechanisms and technologies, AtG Therapeutics seeks to enhance the quality of life for patients affected by cancer, addressing a significant challenge in oncology care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.